Loading clinical trials...
Loading clinical trials...
First Clinical Feasibility Study Using the CellFX® Percutaneous Electrode (PE) System for the Treatment of Symptomatic Benign Thyroid Nodules
Conditions
Interventions
CellFX® Percutaneous Electrode (PE) System
Locations
1
Italy
Ospedale del Mare | ASLNA1 Centro
Naples, Italy
Start Date
April 13, 2023
Primary Completion Date
November 18, 2024
Completion Date
November 18, 2024
Last Updated
November 21, 2024
NCT06729762
NCT04233398
NCT04410601
Lead Sponsor
Pulse Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions